🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the manufacturers of Tylenol, claiming the firms withheld alleged dangers that the pain reliever created to children's neurological development.

The court filing arrives a month after Donald Trump advocated an unsubstantiated connection between using Tylenol - referred to as paracetamol - throughout gestation and autism spectrum disorder in young ones.

The attorney general is suing Johnson & Johnson, which formerly manufactured the medication, the sole analgesic approved for expectant mothers, and Kenvue, which presently makes it.

In a statement, he said they "deceived the public by profiting off of suffering and marketing drugs ignoring the dangers."

Kenvue asserts there is no credible evidence connecting acetaminophen to autism spectrum disorder.

"These manufacturers deceived for years, deliberately risking numerous people to line their pockets," Paxton, from the Republican party, declared.

The manufacturer stated officially that it was "very worried by the spread of false claims on the security of paracetamol and the potential impact that could have on the health of American women and children."

On its online platform, Kenvue also said it had "consistently assessed the pertinent research and there is lacking reliable evidence that demonstrates a proven link between consuming paracetamol and autism."

Organizations representing doctors and healthcare providers agree.

The leading OB-GYN organization has declared acetaminophen - the main ingredient in acetaminophen - is a restricted selection for pregnant women to manage pain and fever, which can pose significant medical dangers if ignored.

"In over twenty years of studies on the consumption of acetaminophen in gestation, not a single reputable study has definitively established that the consumption of paracetamol in any stage of gestation results in neurodevelopmental disorders in offspring," the organization stated.

The court filing cites recent announcements from the Trump administration in asserting the drug is allegedly unsafe.

Recently, the former president raised alarms from medical authorities when he told pregnant women to "resist strongly" not to use acetaminophen when sick.

The US Food and Drug Administration then released a statement that doctors should contemplate reducing the usage of Tylenol, while also stating that "a proven link" between the medication and autism spectrum disorder in minors has not been established.

Health Secretary Kennedy, who supervises the Food and Drug Administration, had pledged in April to conduct "comprehensive study program" that would establish the source of autism spectrum disorder in a short period.

But experts warned that identifying a single cause of autism - thought by researchers to be the consequence of a complex mix of inherited and external influences - would not be simple.

Autism is a form of lifelong neurodivergence and condition that impacts how persons encounter and relate to the surroundings, and is recognized using physician assessments.

In his legal document, Paxton - a Trump ally who is campaigning for the Senate - asserts the manufacturer and Johnson & Johnson "deliberately disregarded and tried to quiet the evidence" around acetaminophen and autism spectrum disorder.

This legal action aims to force the companies "remove any promotional materials" that claims Tylenol is reliable for women during pregnancy.

This legal action mirrors the grievances of a assembly of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in 2022.

The court dismissed the case, declaring research from the plaintiffs' authorities was not conclusive.